Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants
about
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanismsA common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South AsiaAnimal and in silico models for the study of sarcomeric cardiomyopathiesThe ubiquitin-proteasome system and cardiovascular diseaseTargeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategiesHow do MYBPC3 mutations cause hypertrophic cardiomyopathy?The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathyAdrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in miceDefective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophyUbiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathiesRescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in miceIn the thick of it: HCM-causing mutations in myosin binding proteins of the thick filamentThe A31P missense mutation in cardiac myosin binding protein C alters protein structure but does not cause haploinsufficiency.Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 geneThe ubiquitin-proteasome system in myocardial ischaemia and preconditioning.The ubiquitin proteasome system in human cardiomyopathies and heart failure.The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2).Hypertrophic cardiomyopathy: from genetics to treatmentExperimental therapies in hypertrophic cardiomyopathyAssociation of 25 bp deletion in MYBPC3 gene with left ventricle dysfunction in coronary artery disease patients.Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathyTubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy.Signaling and myosin-binding protein C.Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunctionAtg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes.Proteasome functional insufficiency in cardiac pathogenesis.Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and diseaseCardiac myosin binding protein-C: redefining its structure and function.Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome SequencingDissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice.Breaking down protein degradation mechanisms in cardiac muscle.Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains.Protein quality control and degradation in cardiomyocytes.Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy.Build it up-Tear it down: protein quality control in the cardiac sarcomere.Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T MutationsExpression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.Effects of contractile protein phosphorylation on force development in permeabilized rat cardiac myocytes.
P2860
Q24309993-E11704B2-8077-4B34-BF0B-5C7D871073ADQ24645034-63961E1E-C9AC-4148-8225-CD4C4DF489E8Q26865437-17198C7B-CF11-47A4-83FE-C522A5619C98Q27021582-699E3292-1A4B-4293-A7DB-073537FBDB39Q27026951-784B06F7-377F-485B-8DFF-A23F441CCEBCQ28252351-BCC1C8CB-E46F-4CF8-87F8-4B16159EC577Q28252486-92A482F6-97EC-49B5-8017-BC7EDCA622BBQ28252819-E9ACA35B-22EA-4386-99A8-CB467EB8B6C2Q28255924-5F4A9282-AEDA-4D01-BBBC-04FB9E187C27Q28273319-C77B7463-7FFC-48AF-91BD-744071D82FBCQ28291547-918735D6-1BBA-4CFE-B98B-50E45878F4F0Q28307598-6FF74620-23D4-41C9-B2E0-24AC8FB2386DQ30383609-742F545D-391A-4161-9882-102F521EF838Q33379935-4A2E0699-6E3A-417C-9470-7525CE991ECCQ33554506-B2FC93AD-E40F-45FA-B4DE-B6350C719766Q33816688-890148EE-CC64-46CE-BE2B-5D66F9B3E6CCQ33919062-9CC3B5F1-5A83-451C-9D35-D7554F68EC95Q33992358-4EC343A8-8F11-40CC-B397-316EAD4F42FCQ33997765-BED9BE11-2675-4F1B-A555-0F113DD6B8ADQ34018918-5B2AF175-9E47-4837-9636-BD18B872E820Q34592321-A7AD8F69-A90B-4511-8972-5DB1170725C5Q34626001-AB6FA724-5720-40FC-AC7F-68548596BB90Q34661083-0AC9D9E6-8B64-4116-80AE-1A6245570EF7Q34696154-D7017535-04AC-42D0-A6AD-518428903A04Q34781987-8AA8BCCF-5E8D-4901-9DDB-C39E06B0FC69Q35126714-0FFA513D-1448-4F63-A21C-C648B6A2A223Q35149003-171E2A66-3198-421A-B25C-9159BD3A2E2CQ35601400-A2B1E95F-1E32-458C-B08B-97777D8263C9Q36027981-465D398F-8EAB-438E-8E01-D74D52095ABFQ36030150-C96DF01D-C74B-444F-B8E1-C008FE69562FQ36287303-59F29276-C704-4F60-AB3F-932168F9DD4FQ36303049-15E8121D-AC26-447F-889A-2C6C407D33B8Q36756282-94E4B77B-913B-45DD-9ADE-2CC742F48622Q36843579-7FF952F5-807D-4A5E-A376-E458EBD7EB9AQ36952213-B7346A3B-65EA-4CA7-AADE-CFCED83D2F43Q37275558-7FD2FDDC-9E67-4CBF-8B8C-103C3BD9614EQ37313697-EDCEC10B-6DDE-4F36-9917-D1D5D4ABB398Q37372239-181D8C70-C7DC-4C43-A231-2E36DC76BC20Q37394759-4F07D993-0D4B-4A8E-BA8D-71BBF8AE63FEQ37428711-65F42A01-B20C-4567-A2EA-3877B34B568F
P2860
Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants
description
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im April 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: April 2005)
@en
vedecký článok (publikovaný 2005/04/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/04/01)
@nl
наукова стаття, опублікована у квітні 2005
@uk
مقالة علمية (نشرت في أبريل 2005)
@ar
name
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@ast
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@en
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@nl
type
label
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@ast
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@en
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@nl
prefLabel
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@ast
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@en
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@nl
P2093
P1476
Impairment of the ubiquitin-pr ...... osin binding protein C mutants
@en
P2093
Antonio Sarikas
Carolus Schenke
Daniela Doll
Jeanne Flavigny
Katrin S Lindenberg
Thomas Eschenhagen
P356
10.1016/J.CARDIORES.2005.01.004
P407
P577
2005-04-01T00:00:00Z